Lisanti Capital Growth’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-8,845
| Closed | -$3.65M | – | 123 |
|
|
2021
Q3 | $3.65M | Buy |
8,845
+1,725
| +24% | +$712K | 0.54% | 76 |
|
|
2021
Q2 | $2.63M | Sell |
7,120
-10,890
| -60% | -$4.03M | 0.33% | 107 |
|
|
2021
Q1 | $5.22M | Buy |
18,010
+9,185
| +104% | +$2.66M | 0.67% | 66 |
|
|
2020
Q4 | $2.21M | Hold |
8,825
| – | – | 0.31% | 99 |
|
|
2020
Q3 | $2M | Buy |
8,825
+2,290
| +35% | +$518K | 0.37% | 85 |
|
|
2020
Q2 | $1.14M | Buy |
+6,535
| New | +$1.14M | 0.23% | 106 |
|